Eli Lilly: The economics of innovation

We regularly explore the investment rationale behind one of the companies held in our portfolio to articulate what we find compelling. This time around, we have chosen Eli Lilly, a business that we believe stands at the intersection of scientific innovation, and one of the most important secular growth opportunities in global healthcare.